Revolutionary Parkinson’s Treatment Now Available on the NHS

A groundbreaking Parkinson’s treatment that uses advanced brain stimulation to control tremors and stiffness has been introduced on the NHS, offering new hope to those living with the condition. The new device, called adaptive deep brain stimulation (DBS), monitors brain activity in real time and adjusts electrical impulses automatically to match a patient’s needs. This upgrade improves on older DBS implants, which provided a constant level of stimulation regardless of how symptoms changed throughout the day. More than 150,000 people in the UK live with Parkinson’s disease, a neurological disorder caused by the loss of nerve cells in the brain. While the condition is incurable, DBS has been a key treatment since the 1980s. It delivers electrical impulses via an implant to reduce debilitating symptoms like tremors and stiffness. Traditional DBS devices were set at a fixed strength and frequency, but Parkinson’s symptoms often fluctuate depending on the time of day, medication effectiveness, or other factors. The adaptive DBS system solves this issue by fine-tuning the stimulation to meet the patient’s needs in real-time, offering greater symptom control and improving quality of life. The first UK patients to receive this new technology, developed by Medtronic, were treated at North Bristol and Newcastle Hospitals NHS Foundation Trust. “For the first time, we’re able to fine-tune the technology to give patients a better quality of life,” said Dr Mohammed Hussain, a consultant neurosurgeon at the Royal Victoria Infirmary in Newcastle. The new adaptive DBS is expected to benefit 300 patients each year. While the treatment involves invasive surgery to implant the device, it is offered to patients who don’t respond to other treatments like medication or muscle-strengthening exercises. Experts believe the technology will not only improve patients’ lives but also reduce the need for frequent hospital visits. This cutting-edge treatment marks a significant step forward in managing Parkinson’s symptoms and provides much-needed hope for those living with the condition.